Explore detailed financial insights for NSE: Bajaj HealthCare Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Bajaj HealthCare Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Bajajhcare, including updates on board meetings and corporate actions.

BAJAJHCARE
Bajaj HealthCare Limited - https://www.bajajhealth.com
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl xanthine, bromoethyl theophylline, calcium phosphoryl choline chloride, 4-hydrazinobenzoic acid, ticagrelor acetonide, 4,7-dichloroquinolone, 5-[N-ethyl-N-(2-hydroxyethyl)amino]-2-aminopentane, 2-amino -4-hydroxyacetophenone, 8- chloro theophylline, 8 bromo-3-methyl xanthine, 3-methyl-7-(2-butyn-1-yl)-8-bromo xanthine, (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile, 3 – amino – 1 – adamantanol, N – boc -sitagliptin, sitagliptin base, hesperidine, (2,7-dichlori-9H-fluorene), (2-Chloro-1-(2,7- dichlori-9H-fluoren-4-yl)ethanone), (2-(dibutylamino)-1-(2, 7- dichlori-9H-fluoren-4-yl)ethanol), (2-Nitro-4-thiocyanoaniline), 4- (propylthio) benzene -1,2-diamine, methyl [(E)amino(methylsulfanyl)methylidene] carbamate, and (2-phenoxy methane sulphonamide). In addition, the company offers formulations in the form of tablets, capsules, sachets, and vials, as well as impurities. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.

Bajaj HealthCare Limited Share Price Today

644.10
OPEN
689.85
HIGH
627.40
LOW
641.90
CLOSE
952 K
VOLUME
1,819 Cr
Market Cap
432043
Average Volume
Healthcare
Sector
NSI
Exchange

Bajaj HealthCare Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: BAJAJHCARE Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date
Bajaj Healthcare Limited
BAJAJHCARE
INE411U01027
Annual General Meeting/Dividend - Re 1 Per Share
23 Sep 2024
5
N/A
Bajaj Healthcare Limited
BAJAJHCARE
INE411U01027
Annual General Meeting/Dividend - Re 1 Per Share
22 Sep 2023
5
N/A
Bajaj Healthcare Limited
BAJAJHCARE
INE411U01027
Annual General Meeting/Dividend - Rs 1.50 Per Share
22 Sep 2022
5
N/A

NSE: BAJAJHCARE Recent Announcements

Symbol
Date
Description
Industry
BAJAJHCARE
03 Jan 2025, 15:01:06
Updates
N/A
BAJAJHCARE
27 Dec 2024, 17:28:11
Trading Window-XBRL
N/A
BAJAJHCARE
27 Dec 2024, 17:27:13
Trading Window
N/A
BAJAJHCARE
23 Dec 2024, 18:51:39
Disclosure under SEBI Takeover Regulations
N/A
BAJAJHCARE
20 Dec 2024, 13:04:35
Price movement
N/A

NSE: BAJAJHCARE Corporate Governance

Name
Symbol
Timestamp
Submission Date
XBRL Document
Bajaj Healthcare Limited
BAJAJHCARE
21 Oct 2024, 14:35:00
21 Oct 2024, 14:35:00
Bajaj Healthcare Limited
BAJAJHCARE
19 Jul 2024, 13:44:00
19 Jul 2024, 13:44:00
Bajaj Healthcare Limited
BAJAJHCARE
16 Oct 2024, 14:18:00
16 Oct 2024, 14:18:00
Bajaj Healthcare Limited
BAJAJHCARE
19 Jan 2024, 17:45:00
19 Jan 2024, 18:15:00
Bajaj Healthcare Limited
BAJAJHCARE
17 Oct 2023, 18:45:00
17 Oct 2023, 19:15:00

NSE: BAJAJHCARE Detailed Governance

Category
Date of Birth
Date of Initial Appointment
DIN
Director Name
Status
Chairperson & Executive Director-MD
09 Nov 1959
01 Apr 2002
00225950
Sajankumar Rameshwarlal Bajaj
-
Executive Director-MD
07 Oct 1974
15 Jan 2004
00226137
Anil Champalal Jain
-
Executive Director
25 Mar 1971
01 Apr 2005
00226390
Dhananjay Sabaji Hatle
-
Executive Director
07 Jul 1985
11 Jan 2013
05327071
Namrata Sajankumar Bajaj
-
Executive Director
12 Apr 1998
30 Jun 2020
08776385
Pakshal Anil Jain
-

NSE: BAJAJHCARE Board Meetings

Purpose
Symbol
Industry
ISIN
Name
Time
Board Meeting Intimation
BAJAJHCARE
N/A
INE411U01027
Bajaj Healthcare Limited
11 Nov 2024, 16:59:45
BAJAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 19-Sep-2024 to consider Fund raising.
BAJAJHCARE
N/A
INE411U01027
Bajaj Healthcare Limited
18 Sep 2024, 13:30:02
Financial Results/Other business matters
BAJAJHCARE
N/A
INE411U01027
Bajaj Healthcare Limited
08 Aug 2024, 19:01:36
BAJAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 10-Jul-2024 to consider and approve Increase in authorised capital/Fund raising/Other business.
BAJAJHCARE
N/A
INE411U01027
Bajaj Healthcare Limited
05 Jul 2024, 19:31:15
BAJAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business.
BAJAJHCARE
N/A
INE411U01027
Bajaj Healthcare Limited
16 May 2024, 19:40:34

NSE: BAJAJHCARE Event Calendar

Purpose
Symbol
Industry
ISIN
Name
Time
Description
Financial Results
BAJAJHCARE
-
INE411U01027
Bajaj Healthcare Limited
11 Nov 2024, 00:00:00
To consider and approve the financial results for the period ended September 30, 2024
Other business matters
BAJAJHCARE
-
INE411U01027
Bajaj Healthcare Limited
16 Sep 2024, 00:00:00
To consider allotment of Equity shares and Warrants on preferential basis
Financial Results/Other business matters
BAJAJHCARE
-
INE411U01027
Bajaj Healthcare Limited
08 Aug 2024, 00:00:00
To consider and approve the financial results for the period ended Jun 30, 2024, ESOP other business matters
Fund Raising/Other business matters
BAJAJHCARE
-
INE411U01027
Bajaj Healthcare Limited
05 Jul 2024, 00:00:00
To consider Fund Raising and other business matters
Financial Results/Dividend
BAJAJHCARE
-
INE411U01027
Bajaj Healthcare Limited
16 May 2024, 00:00:00
To consider and approve the financial results for the period ended March 31, 2024 and dividend

NSE: BAJAJHCARE Balance Sheet Data In (Cr)

date period_type Ordinary Shares Number Share Issued Net Debt Total Debt Tangible Book Value Invested Capital Working Capital Net Tangible Assets Capital Lease Obligations Common Stock Equity Total Capitalization Total Equity Gross Minority Interest Stockholders Equity Other Equity Interest Fixed Assets Revaluation Reserve Retained Earnings Additional Paid In Capital Capital Stock Common Stock Total Liabilities Net Minority Interest Total Non Current Liabilities Net Minority Interest Other Non Current Liabilities Non Current Pension And Other Postretirement Benefit Plans Non Current Deferred Taxes Liabilities Long Term Debt And Capital Lease Obligation Long Term Capital Lease Obligation Long Term Debt Long Term Provisions Current Liabilities Other Current Liabilities Current Deferred Taxes Liabilities Current Debt And Capital Lease Obligation Current Capital Lease Obligation Current Debt Pensionand Other Post Retirement Benefit Plans Current Current Provisions Payables Other Payable Total Tax Payable Accounts Payable Total Assets Total Non Current Assets Other Non Current Assets Non Current Deferred Taxes Assets Investmentin Financial Assets Available For Sale Securities Goodwill And Other Intangible Assets Other Intangible Assets Net PPE Accumulated Depreciation Gross PPE Construction In Progress Other Properties Machinery Furniture Equipment Buildings And Improvements Land And Improvements Properties Current Assets Other Current Assets Assets Held For Sale Current Restricted Cash Prepaid Assets Inventory Other Inventories Finished Goods Raw Materials Other Receivables Taxes Receivable Accounts Receivable Allowance For Doubtful Accounts Receivable Gross Accounts Receivable Cash Cash Equivalents And Short Term Investments Other Short Term Investments Cash And Cash Equivalents Cash Equivalents Cash Financial
2024-09-30T00:00:00 quarterly 31,583,252.00 31,583,252.00 1,836,056,000.00 2,057,424,000.00 4,440,675,000.00 6,509,018,000.00 2,108,178,000.00 4,440,675,000.00 6,689,000.00 4,458,283,000.00 4,771,047,000.00 4,458,283,000.00 4,458,283,000.00 4,300,367,000.00 0.00 0.00 0.00 157,916,000.00 157,916,000.00 3,581,191,000.00 378,687,000.00 0.00 0.00 0.00 317,466,000.00 4,702,000.00 312,764,000.00 61,221,000.00 3,202,504,000.00 62,948,000.00 0.00 1,739,958,000.00 1,987,000.00 1,737,971,000.00 0.00 23,351,000.00 904,656,000.00 0.00 0.00 904,656,000.00 8,039,474,000.00 2,728,792,000.00 0.00 182,410,000.00 34,303,000.00 34,303,000.00 17,608,000.00 17,608,000.00 2,482,932,000.00 0.00 2,482,932,000.00 96,897,000.00 2,386,035,000.00 0.00 0.00 0.00 0.00 5,310,682,000.00 382,713,000.00 755,098,000.00 0.00 0.00 1,424,303,000.00 0.00 0.00 0.00 0.00 0.00 2,168,560,000.00 0.00 0.00 580,008,000.00 365,329,000.00 214,679,000.00 0.00 0.00
2024-03-31T00:00:00 quarterly 27,598,400.00 27,598,400.00 3,298,946,000.00 3,328,243,000.00 2,765,481,000.00 6,104,302,000.00 286,175,000.00 2,765,481,000.00 7,550,000.00 2,783,609,000.00 3,169,390,000.00 2,783,609,000.00 2,783,609,000.00 2,645,617,000.00 0.00 2,673,819,000.00 0.00 137,992,000.00 137,992,000.00 4,867,668,000.00 452,876,000.00 0.00 61,392,000.00 0.00 391,484,000.00 5,703,000.00 385,781,000.00 61,392,000.00 4,414,792,000.00 300,000.00 0.00 2,936,759,000.00 1,847,000.00 2,934,912,000.00 35,216,000.00 1,235,000.00 1,027,556,000.00 133,291,000.00 0.00 894,265,000.00 7,651,277,000.00 2,850,753,000.00 1,000.00 218,571,000.00 33,000.00 33,000.00 18,128,000.00 18,128,000.00 2,575,581,000.00 -1,702,289,000.00 4,277,870,000.00 48,038,000.00 10,320,000.00 2,615,299,000.00 917,691,000.00 686,522,000.00 0.00 4,700,967,000.00 423,099,000.00 755,098,000.00 0.00 324,820,000.00 1,440,382,000.00 0.00 482,540,000.00 957,842,000.00 348,979,000.00 0.00 1,802,400,000.00 -58,366,000.00 1,860,766,000.00 29,288,000.00 7,541,000.00 21,747,000.00 0.00 21,747,000.00
2024-03-31T00:00:00 annual 27,598,400.00 27,598,400.00 3,298,946,000.00 3,328,243,000.00 2,765,481,000.00 6,104,302,000.00 286,175,000.00 2,765,481,000.00 7,550,000.00 2,783,609,000.00 3,169,390,000.00 2,783,609,000.00 2,783,609,000.00 2,645,617,000.00 0.00 2,673,819,000.00 0.00 137,992,000.00 137,992,000.00 4,867,668,000.00 452,876,000.00 0.00 61,392,000.00 0.00 391,484,000.00 5,703,000.00 385,781,000.00 61,392,000.00 4,414,792,000.00 300,000.00 0.00 2,936,759,000.00 1,847,000.00 2,934,912,000.00 35,216,000.00 1,235,000.00 1,027,556,000.00 133,291,000.00 0.00 894,265,000.00 7,651,277,000.00 2,850,753,000.00 1,000.00 218,571,000.00 33,000.00 33,000.00 18,128,000.00 18,128,000.00 2,575,581,000.00 -1,702,289,000.00 4,277,870,000.00 48,038,000.00 10,320,000.00 2,615,299,000.00 917,691,000.00 686,522,000.00 0.00 4,700,967,000.00 423,099,000.00 755,098,000.00 0.00 324,820,000.00 1,440,382,000.00 0.00 482,540,000.00 957,842,000.00 348,979,000.00 0.00 1,802,400,000.00 -58,366,000.00 1,860,766,000.00 29,288,000.00 7,541,000.00 21,747,000.00 0.00 21,747,000.00
2023-09-30T00:00:00 quarterly 27,598,400.00 27,598,400.00 3,505,928,000.00 3,569,458,000.00 3,145,300,000.00 6,722,522,000.00 1,067,464,000.00 3,145,300,000.00 8,384,000.00 3,161,448,000.00 3,736,309,000.00 3,161,448,000.00 3,161,448,000.00 3,023,456,000.00 0.00 0.00 0.00 137,992,000.00 137,992,000.00 5,217,699,000.00 610,202,000.00 0.00 0.00 0.00 581,532,000.00 6,671,000.00 574,861,000.00 28,670,000.00 4,607,497,000.00 18,417,000.00 0.00 2,987,926,000.00 1,713,000.00 2,986,213,000.00 0.00 2,246,000.00 945,949,000.00 0.00 133,718,000.00 812,231,000.00 8,379,147,000.00 2,704,186,000.00 0.00 22,000,000.00 96,009,000.00 96,009,000.00 16,148,000.00 16,148,000.00 2,570,029,000.00 0.00 2,570,029,000.00 139,279,000.00 2,430,750,000.00 0.00 0.00 0.00 0.00 5,674,961,000.00 426,866,000.00 908,583,000.00 0.00 0.00 2,027,900,000.00 0.00 0.00 0.00 48,240,000.00 0.00 2,199,190,000.00 0.00 0.00 64,182,000.00 9,036,000.00 55,146,000.00 0.00 0.00
2023-03-31T00:00:00 quarterly 27,598,400.00 27,598,400.00 3,966,096,000.00 4,152,437,000.00 3,663,039,000.00 7,820,195,000.00 668,046,000.00 3,663,039,000.00 9,137,000.00 3,676,895,000.00 4,613,511,000.00 3,676,895,000.00 3,676,895,000.00 3,538,902,000.00 0.00 3,539,349,000.00 0.00 137,992,000.00 137,992,000.00 5,299,708,000.00 963,723,000.00 -1,000.00 14,509,000.00 5,049,000.00 944,166,000.00 7,550,000.00 936,616,000.00 27,912,000.00 4,335,985,000.00 300,000.00 102,858,000.00 3,208,271,000.00 1,587,000.00 3,206,684,000.00 52,048,000.00 2,557,000.00 958,333,000.00 110,804,000.00 140,873,000.00 847,529,000.00 8,976,603,000.00 3,972,572,000.00 -2,408,000.00 0.00 33,000.00 33,000.00 13,856,000.00 13,856,000.00 3,860,313,000.00 -1,593,233,000.00 5,453,546,000.00 203,432,000.00 10,320,000.00 3,205,195,000.00 1,166,178,000.00 868,421,000.00 0.00 5,004,031,000.00 512,217,000.00 0.00 0.00 405,692,000.00 2,087,867,000.00 68,194,000.00 655,459,000.00 1,432,408,000.00 338,503,000.00 38,016,000.00 1,941,661,000.00 -58,366,000.00 2,000,027,000.00 192,292,000.00 15,088,000.00 177,204,000.00 0.00 177,204,000.00
2023-03-31T00:00:00 annual 27,598,400.00 27,598,400.00 3,966,096,000.00 4,152,437,000.00 3,663,039,000.00 7,820,195,000.00 668,046,000.00 3,663,039,000.00 9,137,000.00 3,676,895,000.00 4,613,511,000.00 3,676,895,000.00 3,676,895,000.00 3,538,902,000.00 0.00 3,539,349,000.00 0.00 137,992,000.00 137,992,000.00 5,299,708,000.00 963,723,000.00 -1,000.00 14,509,000.00 5,049,000.00 944,166,000.00 7,550,000.00 936,616,000.00 27,912,000.00 4,335,985,000.00 300,000.00 102,858,000.00 3,208,271,000.00 1,587,000.00 3,206,684,000.00 52,048,000.00 2,557,000.00 958,333,000.00 110,804,000.00 140,873,000.00 847,529,000.00 8,976,603,000.00 3,972,572,000.00 -2,408,000.00 0.00 33,000.00 33,000.00 13,856,000.00 13,856,000.00 3,860,313,000.00 -1,593,233,000.00 5,453,546,000.00 203,432,000.00 10,320,000.00 3,205,195,000.00 1,166,178,000.00 868,421,000.00 0.00 5,004,031,000.00 512,217,000.00 0.00 0.00 405,692,000.00 2,087,867,000.00 68,194,000.00 655,459,000.00 1,432,408,000.00 338,503,000.00 38,016,000.00 1,941,661,000.00 -58,366,000.00 2,000,027,000.00 192,292,000.00 15,088,000.00 177,204,000.00 0.00 177,204,000.00
2022-03-31T00:00:00 annual 27,598,400.00 27,598,400.00 2,547,607,000.00 2,567,357,000.00 3,284,855,000.00 5,852,212,000.00 762,373,000.00 3,284,855,000.00 0.00 3,284,855,000.00 3,947,955,000.00 3,284,855,000.00 3,284,855,000.00 3,146,863,000.00 0.00 3,150,502,000.00 0.00 137,992,000.00 137,992,000.00 3,926,179,000.00 705,449,000.00 0.00 0.00 15,632,000.00 663,100,000.00 0.00 663,100,000.00 26,717,000.00 3,220,730,000.00 11,655,000.00 92,815,000.00 1,904,257,000.00 0.00 1,904,257,000.00 0.00 2,288,000.00 1,215,447,000.00 166,246,000.00 92,815,000.00 1,049,201,000.00 7,211,034,000.00 3,227,930,000.00 1,000.00 0.00 31,000.00 31,000.00 0.00 0.00 3,217,159,000.00 -1,319,850,000.00 4,537,009,000.00 519,758,000.00 44,326,000.00 2,301,682,000.00 847,348,000.00 868,221,000.00 0.00 3,983,103,000.00 1,000.00 0.00 0.00 143,541,000.00 1,592,618,000.00 -1,000.00 165,803,000.00 1,426,816,000.00 70,505,000.00 311,571,000.00 1,845,118,000.00 -13,135,000.00 1,858,253,000.00 19,750,000.00 110,158,000.00 19,750,000.00 0.00 19,751,000.00
2021-03-31T00:00:00 annual 27,598,400.00 27,598,400.00 1,666,445,000.00 1,808,856,000.00 2,584,105,000.00 4,392,961,000.00 757,598,000.00 2,584,105,000.00 0.00 2,584,105,000.00 3,381,238,000.00 2,584,105,000.00 2,584,105,000.00 2,446,113,000.00 0.00 2,450,442,000.00 0.00 137,992,000.00 137,992,000.00 2,672,211,000.00 846,478,000.00 -1,000.00 0.00 21,540,000.00 797,133,000.00 0.00 797,133,000.00 27,806,000.00 1,825,733,000.00 14,929,000.00 0.00 1,011,723,000.00 0.00 1,011,723,000.00 0.00 1,779,000.00 802,633,000.00 113,096,000.00 0.00 689,537,000.00 5,256,316,000.00 2,672,986,000.00 -1,000.00 0.00 31,000.00 31,000.00 0.00 0.00 2,651,752,000.00 -1,211,271,000.00 3,863,023,000.00 570,474,000.00 44,326,000.00 1,661,776,000.00 718,226,000.00 868,221,000.00 0.00 2,583,331,000.00 474,356,000.00 0.00 0.00 183,776,000.00 971,103,000.00 5,957,000.00 128,103,000.00 843,000,000.00 2,648,000.00 294,565,000.00 988,828,000.00 -8,984,000.00 997,812,000.00 142,411,000.00 6,633,000.00 142,411,000.00 0.00 142,411,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 395,850,635.00 0.00 0.00 0.00 0.00 0.00 0.00 -1,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4,400,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18,410,193.00 0.00 0.00 8,754,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: BAJAJHCARE Cash Flow Data In (Cr)

date period_type Free Cash Flow Capital Expenditure End Cash Position Other Cash Adjustment Outside Changein Cash Beginning Cash Position Changes In Cash Financing Cash Flow Net Other Financing Charges Interest Paid Cff Cash Dividends Paid Common Stock Dividend Paid Net Issuance Payments Of Debt Net Short Term Debt Issuance Net Long Term Debt Issuance Investing Cash Flow Net Other Investing Changes Interest Received Cfi Dividends Received Cfi Net Investment Purchase And Sale Sale Of Investment Purchase Of Investment Net PPE Purchase And Sale Sale Of PPE Purchase Of PPE Operating Cash Flow Taxes Refund Paid Change In Working Capital Change In Other Current Liabilities Change In Other Current Assets Change In Inventory Change In Receivables Other Non Cash Items Provisionand Write Offof Assets Depreciation And Amortization Depreciation Pension And Employee Benefit Expense Gain Loss On Investment Securities Net Foreign Currency Exchange Gain Loss Gain Loss On Sale Of PPE Net Income From Continuing Operations
2024-03-31T00:00:00 annual 620,081,000.00 -302,863,000.00 21,747,000.00 0.00 177,204,000.00 -155,457,000.00 -965,955,000.00 -2,000.00 -418,755,000.00 -27,598,000.00 0.00 -517,296,000.00 -331,633,000.00 -185,663,000.00 -112,446,000.00 7,547,000.00 3,200,000.00 0.00 67,170,000.00 67,170,000.00 0.00 -190,363,000.00 112,500,000.00 -302,863,000.00 922,944,000.00 -127,860,000.00 385,057,000.00 194,098,000.00 -139,205,000.00 204,204,000.00 125,960,000.00 858,784,000.00 0.00 314,473,000.00 314,473,000.00 6,449,000.00 513,758,000.00 11,293,000.00 -359,000.00 -1,038,651,000.00
2023-03-31T00:00:00 annual -1,157,879,000.00 -935,950,000.00 177,204,000.00 -1,000.00 19,750,000.00 157,455,000.00 1,313,652,000.00 1,000.00 -228,724,000.00 -41,398,000.00 0.00 1,585,079,000.00 1,141,715,000.00 443,364,000.00 -934,268,000.00 -5,946,000.00 2,353,000.00 0.00 0.00 0.00 0.00 -930,675,000.00 5,275,000.00 -935,950,000.00 -221,929,000.00 -115,365,000.00 -1,247,585,000.00 -213,263,000.00 -64,833,000.00 -495,249,000.00 -474,240,000.00 226,342,000.00 45,231,000.00 273,554,000.00 273,554,000.00 13,771,000.00 -41,000.00 0.00 -41,000.00 582,164,000.00
2022-03-31T00:00:00 annual -786,189,000.00 -793,049,000.00 19,750,000.00 -1,000.00 142,411,000.00 -122,660,000.00 618,463,000.00 -1,000.00 -126,238,000.00 -13,799,000.00 0.00 758,501,000.00 877,325,000.00 -118,824,000.00 -747,983,000.00 -7,803,000.00 1,717,000.00 0.00 0.00 0.00 0.00 -741,897,000.00 51,152,000.00 -793,049,000.00 6,860,000.00 -96,312,000.00 -1,108,396,000.00 407,724,000.00 -34,164,000.00 -621,515,000.00 -860,441,000.00 124,521,000.00 4,151,000.00 176,366,000.00 176,366,000.00 9,562,000.00 121,000.00 0.00 0.00 896,846,000.00
2021-03-31T00:00:00 annual -702,304,000.00 -1,137,887,000.00 142,411,000.00 -10,000.00 41,585,000.00 100,826,000.00 754,573,000.00 1,000.00 -82,960,000.00 -24,149,000.00 0.00 861,681,000.00 304,316,000.00 557,365,000.00 -1,089,330,000.00 -5,008,000.00 1,669,000.00 0.00 50,000,000.00 50,000,000.00 0.00 -1,135,991,000.00 1,896,000.00 -1,137,887,000.00 435,583,000.00 -356,514,000.00 -640,918,000.00 152,659,000.00 -218,737,000.00 -578,352,000.00 3,512,000.00 81,291,000.00 -7,563,000.00 161,242,000.00 161,242,000.00 9,964,000.00 -116,000.00 0.00 0.00 1,188,197,000.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4,000.00 0.00 0.00 -50,000,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NSE: BAJAJHCARE Income Statement Data In (Cr)

date period_type Tax Effect Of Unusual Items Tax Rate For Calcs Normalized EBITDA Total Unusual Items Total Unusual Items Excluding Goodwill Net Income From Continuing Operation Net Minority Interest Reconciled Depreciation Reconciled Cost Of Revenue EBITDA EBIT Net Interest Income Interest Expense Interest Income Normalized Income Net Income From Continuing And Discontinued Operation Total Expenses Rent Expense Supplemental Diluted Average Shares Basic Average Shares Diluted EPS Basic EPS Diluted NI Availto Com Stockholders Net Income Common Stockholders Otherunder Preferred Stock Dividend Net Income Net Income Including Noncontrolling Interests Net Income Discontinuous Operations Net Income Continuous Operations Tax Provision Pretax Income Other Non Operating Income Expenses Special Income Charges Other Special Charges Write Off Net Non Operating Interest Income Expense Total Other Finance Cost Interest Expense Non Operating Interest Income Non Operating Operating Income Operating Expense Other Operating Expenses Depreciation And Amortization In Income Statement Amortization Depreciation Income Statement Selling General And Administration Selling And Marketing Expense General And Administrative Expense Rent And Landing Fees Gross Profit Cost Of Revenue Total Revenue Operating Revenue Net Income Extraordinary
2024-03-31T00:00:00 annual -5.35 0.00 81.79 -37.97 -37.97 -14.33 31.45 259.13 43.83 12.38 -29.42 29.05 0.33 18.29 -83.79 424.70 1.18 2.76 2.76 0.00 0.00 -83.79 -83.79 0.00 -83.79 -83.79 -69.47 -14.33 -2.35 -16.68 0.12 -37.97 37.97 0.00 -29.42 0.69 29.05 0.33 48.71 165.58 55.87 27.62 0.21 27.41 15.41 9.67 5.74 1.18 214.29 259.13 473.42 473.42 0.00
2023-03-31T00:00:00 annual 0.15 0.00 121.13 0.81 0.81 63.53 27.36 386.88 121.94 94.58 -17.25 16.40 0.43 62.87 43.02 551.49 1.46 2.76 2.76 0.00 0.00 43.02 43.02 0.00 43.02 43.02 -20.51 63.53 14.65 78.18 0.31 0.81 -0.82 0.01 -17.25 1.28 16.40 0.43 94.31 164.61 61.59 17.21 0.12 17.09 21.40 15.97 5.43 1.46 258.91 386.88 645.80 645.80 0.00
2022-03-31T00:00:00 annual -0.02 0.00 118.44 -0.11 -0.11 71.39 17.64 496.05 118.32 100.69 -12.61 11.00 0.17 71.48 71.39 575.78 1.23 2.76 2.76 0.00 0.00 71.39 71.39 0.00 71.39 71.39 0.00 71.39 18.30 89.68 0.25 -0.11 0.08 0.03 -12.61 1.78 11.00 0.17 104.11 79.73 13.69 17.64 0.00 17.64 7.07 0.09 6.98 1.23 183.84 496.05 679.89 679.89 0.00
2021-03-31T00:00:00 annual 0.00 0.00 143.28 0.00 0.00 83.11 16.12 462.93 143.28 127.16 -8.17 8.34 0.17 83.11 83.11 534.57 1.25 2.76 2.76 0.00 0.00 83.11 83.11 0.00 83.11 83.11 0.00 83.11 35.71 118.82 1.38 0.00 -0.01 0.01 -8.17 0.00 8.34 0.17 121.21 71.64 13.77 16.12 0.00 16.12 6.14 0.57 5.57 1.25 192.86 462.93 655.78 655.78 0.00
2020-03-31T00:00:00 annual 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

FII & DII Data (In Cr)

Date FII Gross Purchase FII Gross Sales FII Net Purchase / Sales DII Gross Purchase DII Gross Sales DII Net Purchase / Sales
2025-02-03 12,505.92 16,464.29 -3,958.37 19,319.48 16,611.25 2,708.23
2025-01-30 10,513.63 15,096.58 -4,582.95 13,934.35 11,768.46 2,165.89
2025-01-29 7,644.40 10,230.83 -2,586.43 12,871.38 11,078.67 1,792.71
2025-01-27 9,488.57 14,504.03 -5,015.46 16,503.43 9,861.28 6,642.15
2025-01-24 11,230.47 13,988.96 -2,758.49 12,835.41 10,433.10 2,402.31
2025-01-23 13,316.55 18,779.07 -5,462.52 14,412.73 10,700.18 3,712.55
2025-01-22 12,936.64 16,962.89 -4,026.25 15,437.18 11,796.96 3,640.22
Quarterly Results
Profit & Loss
Piotroski F-Score
5/9
0 1 2 3 4 5 6 7 8 9

Key Metrics

EPS

-3.74

P/E

N/A

P/B

5.7108297

Dividend Yield

0.26%

Market Cap

1,819.37 Cr.

Face Value

100.861

Book Value

100.861

ROE

-5.98%

EBITDA Growth

83.48 Cr.

Debt/Equity

119.566

Short Term

Subscribe to unlock this feature

Medium Term

Subscribe to unlock this feature

Long Term

Subscribe to unlock this feature

Yearly Stock Performance Heatmap

Latest Updates

BAJAJHCARE News

Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI

Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:50

BAJAJHCARE News

Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends

"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:47

BAJAJHCARE News

FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore

Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:37

BAJAJHCARE News

Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal

The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:23

BAJAJHCARE News

Apple iPhone SE 4: Price To Features, 11 Things You Need To Know

iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:12

BAJAJHCARE News

Rupee Closed Weaker Against The US Dollar

The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 15:54

BAJAJHCARE News

Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45

Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:09

BAJAJHCARE News

War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel

The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...

Source: www.ndtvprofit.com
Date: 06 Jan 2025, 19:00

Popular Questions

How to Buy bajajhcare Shares on Fincept?

You can buy Bajaj HealthCare Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.

What is the Market Cap of bajajhcare?

The market capitalization of Bajaj HealthCare Limited is ₹1,819 Cr as of 05 Feb 2025.

What are the PE and PB ratios of Bajaj HealthCare Limited?

The PE and PB ratios of Bajaj HealthCare Limited are Not Available and 5.7108297 respectively as of 05 Feb 2025.

What is the 52 Week High of Bajaj HealthCare Limited?

The 52-week high of Bajaj HealthCare Limited is ₹615 as of 05 Feb 2025.

What is the 52 Week Low of Bajaj HealthCare Limited?

The 52-week low of Bajaj HealthCare Limited is ₹263.3 as of 05 Feb 2025.

What are the earnings per share (EPS) for Bajaj HealthCare Limited?

The Earnings Per Share (EPS) of Bajaj HealthCare Limited is ₹-3.74 as per the most recent quarterly results available on Fincept.

What is the ROE (Return on Equity) of Bajaj HealthCare Limited?

The Return on Equity (ROE) of Bajaj HealthCare Limited is -5.98% as per the most recent financial year data. Explore more on Fincept.

BAJAJ-AUTO

View Stock

VOLTAMP

View Stock

MOREPENLAB

View Stock

TIRUMALCHM

View Stock

GVKPIL

View Stock

DAMODARIND

View Stock

SUVEN

View Stock

DIAMONDYD

View Stock

EUROTEXIND

View Stock

ITDCEM

View Stock

TREJHARA

View Stock

NAHARINDUS

View Stock

KIRLOSBROS

View Stock

SETCO

View Stock

CREATIVE

View Stock